PubMed · 11638024
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
K Velle. [Not Available].. https://pubmed.ncbi.nlm.nih.gov/11638024/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
PURPOSE: Precision medicine, also known as personalized medicine, enables the provision of tailored health services to patients. In the prevention, early detection, and treatment of cancers, precision medicine is highly promising, given the increasing use of genomic profiling for diagnosis and adapting therapies in several tumor types. Artificial Intelligence (AI) can support this process by analyzing vast amounts of relevant data. However, high-quality data and financial investments in the health system are essential for the implementation of precision medicine and AI solutions in routine cancer care. DESIGN/METHODOLOGY/APPROACH: Building on the quantitative outcomes of a foresight exercise published in another study, this article collects qualitative data to gain more detailed insights into the future of precision oncology in Belgium and discusses the role of AI in this field. It reports the results of a series of expert workshops, focusing on four hypothetical future scenarios that are centered around technological and economic issues that must be overcome for the widespread use of precision oncology in Belgium. FINDINGS: The study concludes that all four scenarios discussed in the workshops would require supportive policy measures in Belgium, which should go beyond mere technological and economic considerations, such as involving patient associations and the public in policy design or creating multi-disciplinary expert groups for precision medicine. ORIGINALITY/VALUE: To the best of our knowledge, this is the first study to employ foresight methodology to illustrate possible future scenarios, scrutinize feasible approaches for implementing precision oncology in Belgium, and discuss the use of AI in this context.
A 47-year-old Belgian woman acquired yellow fever during a 1-week vacation in The Gambia; she had never been vaccinated against yellow fever. She died of massive gastrointestinal bleeding 7 days after the onset of the first symptoms. This dramatic case demonstrates that it is important for persons to be vaccinated against yellow fever before they travel to countries where yellow fever is endemic, even if the country, like The Gambia, does not require travelers to be vaccinated.
The role of physicians in issuing a death certificate in the Netherlands differs from that in neighbouring countries and the US; there is also a difference in the degree to which professional secrecy plays a role in this respect. In the Netherlands, England and the US the external examination of the dead body is performed primarily by the attending physician, whereas in Belgium and Germany this may be performed by any physician. Competences and tasks of government-appointed officials such as the medical examiner, forensic pathologist and coroner differ widely. In some countries many data concerning the deceased, the findings of the post-mortem examination, the post-mortal symptoms, the cause of death and the manner of death must be recorded on the death certificate, whilst in other countries, including the Netherlands, hardly any data are recorded. It is recommended that Dutch death certificates should state the points to be covered during a post-mortem as well as explicitly stating the circumstances in which the medical examiner should be called in.